Navigation Links
Leading Chemical Weapons Preparedness Companies Announce Partnership to Deploy Break-through Diagnostic Test Internationally
Date:11/24/2011

THE HAGUE, November 24, 2011 /PRNewswire/ --

ProQares - a leading provider of testing, evaluation and certification services for protective equipment against chemical hazards - announced today a partnership with U.S.-based Rapid Pathogen Screening, Inc. (RPS®) - a leading developer of point-of-care diagnostic tests, to deploy the RPS chemical nerve agent detector in numerous countries throughout the European and Asia Pacific regions.  

The RPS chemical nerve agent detector is the first-of-its-kind point-of-care diagnostic test for human exposure to chemical poisons in the blood, including Soman, Sarin, Tabun, and VX, and is capable of detecting low-level chemical nerve agent exposure in 10 minutes or less with only a simple finger-stick blood sample.

"The partnership with RPS complements ProQares' mission to contribute to the protection of humans against toxic threats by providing fast and reliable test results," said Jack van Hoof, Managing Director of ProQares. "Through the partnership, ProQares will support RPS in marketing the RPS chemical nerve agent detector to its worldwide network of government and industrial organizations."

"This partnership will accelerate the deployment of this break-through technology and ensure that governments and other organizations charged with protecting the public from a chemical weapons attack have the most sophisticated tools available," said Robert Van Dine, Chief IP and Government Affairs Officer for RPS.

In June, in his address to the NATO Conference on WMD Arms Control, Disarmament and Non-Proliferation, Ambassador Ahmet Uzümcü, director-general of the Organisation for the Prohibition of Chemical Weapons (OPCW), focused NATO on his concern that "the future use of chemical weapons in a conventional military sense is remote. The misuse, on the other hand, of toxic chemicals, especially in an asymmetric sense, appears to be the more likely scenario."

A single chemical attack in an urban commercial or residential setting can result in tens of thouy" timex="11/24/2011 2:37:52 AM" dirsub="(sands of people that require immediate d...)" id="22399" index="medicine" dir="Leading Chemical Weapons Preparedness Companies Announce Partnership to Deploy Break-through Diagnostic Test Internationally" dir2="Leading Chemical Weapons Preparedness Companies Announce Partnership to Deploy Break-through Diagnostic Test Inter..." keywords1=",medicine,advanced medical technology,medical laboratory technology,medical device technology,latest medical technology" keywords="Leading,Chemical,Weapons,Preparedness,Companies,Announce,Partnership,to,Deploy,Break-through,Diagnostic,Test,Internationally" description="sands of people that require immediate diagnosis and treatment. Treatm...In early 2012 RPS expects to apply the CE mark to the RPS chemical nerve agent detector and begin d... ..." url=u&"/medicine-technology-1/Leading-Chemical-Weapons-Preparedness-Companies-Announce-Partnership-to-Deploy-Break-through-Diagnostic-Test-Internationally-22399-2/" title="Leading%20Chemical%20Weapons%20Preparedness%20Companies%20Announce%20Partnership%20to%20Deploy%20Break-through%20Diagnostic%20Test%20Internationally" %> Leading Chemical Weapons Preparedness Companies Announce Partnership to Deploy Break-through Diagnostic Test Inter... ( THE HAGUE November 24 2011 /- Pro...)

Leading Chemical Weapons Preparedness Companies Announce Partnership to Deploy Break-through Diagnostic Test Internationally
Date:11/24/2011

sands of people that require immediate diagnosis and treatment. Treatment for chemical weapon nerve agent exposure often is most effective within the first 40 minutes. The RPS chemical nerve agent detector responds to this need by providing a rapid, accurate and cost-effective diagnosis at the point-of-care.

In early 2012, RPS expects to apply the CE mark to the RPS chemical nerve agent detector and begin discussions with the U.S. Food and Drug Administration to bring it to market in the United States. The product is not currently CE-marked and is not yet available for sale in the United States.


'/>"/>
SOURCE ProQares
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. PAREXEL Advances Early Phase CNS Research Capabilities With Leading Medical Imaging Technology
2. Qmed, the Leading Global MedTech Industry Resource Announces New Regulatory Tool to Streamline and Simplify the Regulatory and Product Development Process
3. United Spinal Secures Leading Public Policy and Durable Medical Equipment Specialist: Alex Bennewith is New Director of Government Relations
4. Leading Health Organizations and Patient Groups Call for 20 Percent Reduction in Fractures by 2020
5. Patients at Risk for Hepatitis B Are Not Adequately Screened Before Receiving Chemotherapy Leading to the Preventable Reactivation of Hepatitis B Infection
6. The Future of GPCRs in Drug Discovery: Novel technologies, leading companies, and opportunities for target expansion
7. Hypertronics Partners with UBM Canon, the Leading Global Medical Device Industry Source, to Co-Host Strategies for Avoiding Device Failure Seminar
8. American Skin Association Honors Leading Physicians and Scientists; Journalist Deborah Norville
9. Leading Pharmaceutical Companies & Research Institutions Offer IP and Expertise for Use in Treating Neglected Tropical Diseases as Part of WIPO Re:Search
10. Phreesia Continues to Enhance its Market-Leading Eligibility and Benefits Verification Process for Medical Practices
11. CADCA and Leading Makers of OTC Medicines Call Communities to Action During National Medicine Abuse Awareness Month
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/11/2017)... 11, 2017  Thornhill Research Inc. ( ... an $8,049,024 USD five-year, firm-fixed-priced, indefinite-quantity/indefinite-delivery contract by ... Commercial Corporation (CCC) ( Ottawa, Ontario, Canada ... administer general anesthesia to patients requiring emergency medical ... US Marine Corps have been a longtime partner ...
(Date:5/10/2017)... , May 10, 2017 Radiology has become ... its costs have also spiraled to the number one ... to radiology than ever before as the most complete ... a patient with lower back pain an MRI may ... reason for pain, resulting in entirely different treatment protocols.  ...
(Date:5/9/2017)... , May 9, 2017  Oramed Pharmaceuticals Inc. ... a clinical-stage pharmaceutical company focused on the development ... the Canadian Intellectual Property Office has granted Oramed ... Administration of Exenatide". The patent covers Oramed,s invention ... GLP-1 is an incretin hormone that stimulates ...
Breaking Medicine Technology:
(Date:5/26/2017)... (PRWEB) , ... May 26, 2017 , ... Mediaplanet is ... Wound Care" campaign in USA Today, which will educate readers on how to take ... the campaign, a large focus is placed on melanoma. Dancing with the Stars professional, ...
(Date:5/26/2017)... Clara, Calif. (PRWEB) , ... May 26, 2017 ... ... announces the integration of the CareFusion NOX-T3 portable sleep monitor with its Somnoware ... provides a consistent, browser-based interface for diagnostic device operations. With this platform, initializing ...
(Date:5/26/2017)... , ... May 26, 2017 , ... After raising nearly ... Top gadget will continue to be available at a discounted crowdfunding price on ... stress wherever they are, I also wanted to bring a fidget toy to the ...
(Date:5/26/2017)... , ... May 26, 2017 , ... “When the Stars ... Home” is the creation of published author Laura Weigel Douglas, an avid reader who ... in a house that sometimes feels like Green Hills Adventure Camp. She couldn’t be ...
(Date:5/26/2017)... ... , ... Water damage to the flooring of several classrooms at The Fort ... with a number of critical issues to address before students could return to classes. ... little or no disruption to class schedules. Second, the project had to comply with ...
Breaking Medicine News(10 mins):